Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.
The item "Total-Liabilities" stands at 1.84 Trillion Japanese Yens as of 09/30/2025.
As of the end of Astellas Pharma Inc.'s second quarter, the item "Total Liabilities" stands at 1.84 Trillion JPY. This represents a decrease of -0.87 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -4.89 percent compared to the value the year prior.
The 1 year change in percent is -4.89.
The 3 year change in percent is 96.74.
The 5 year change in percent is 102.54.
The 10 year change in percent is 310.62.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Liabilities | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Liabilities | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Liabilities | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Liabilities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Liabilities | 280,205,508,085.11 |